Gonorrhoea is a major public health concern globally. Increasing incidence and sporadic
ceftriaxone-resistant cases, including treatment failures, are growing concerns. The 2020 …

Antimicrobial resistance (AMR) in Neisseria gonorrhoeae is a serious public health problem,
compromising the management and control of gonorrhoea globally. Resistance in N …

Background Gonorrhoea and antimicrobial resistance (AMR) in Neisseria gonorrhoeae are
major health concerns globally. Increased global surveillance of gonococcal AMR is …

The bacterium Neisseria gonorrhoeae causes the sexually transmitted infection (STI)
gonorrhoea, which has an estimated global annual incidence of 86.9 million adults …

Introduction Sexually transmitted infections (STI s) remain prevalent and are increasing in
several populations. Appropriate STI diagnosis is crucial to prevent the transmission and …

Gonorrhea and antimicrobial resistance (AMR) in Neisseria gonorrhoeae are major public
health concerns globally. Dual antimicrobial therapy (mainly ceftriaxone 250–500 mg× 1 …

The ideal laboratory test to detect Neisseria gonorrhoeae (Ng) should be sensitive, specific,
easy to use, rapid, and affordable and should provide information about susceptibility to …

Objectives Novel antimicrobials for treatment of gonorrhoea are imperative. The first-in-class
spiropyrimidinetrione zoliflodacin is promising and currently in an international Phase 3 …

The incidence rates of sexually transmitted infections (STIs), including the four major curable
STIs–chlamydia, gonorrhea, trichomoniasis and, syphilis–continue to increase globally …

Introduction Several nucleic acid amplification tests (NAATs), mostly PCRs, to detect
antimicrobial resistance (AMR) determinants and predict AMR in Neisseria gonorrhoeae are …